Skip to main content
SpringerLink
Log in

Heparin/nafamostat

Bleeding, hyperkaelemia and haemothorax: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Doi S, et al. Preventing thrombosis in a COVID-19 patient by combined therapy with nafamostat and heparin during extracorporeal membrane oxygenation. Acute Medicine and Surgery 7: No. 1, Dec 2020. Available from: URL: http://doi.org/10.1002/ams2.585

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heparin/nafamostat. Reactions Weekly 1842, 195 (2021). https://doi.org/10.1007/s40278-021-90931-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-90931-4

Search

Navigation